A Randomized, Open Label, Single dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of Apetrol ES and Megace® under Fed Conditions in Healthy Male Volunteers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
38
sequences of administered drugs
Asan Medical Center
Seoul, South Korea
Cmax, AUClast
Time frame: Day 34
AUCinf, Tmax, t1/2(beta)
Time frame: Day 34
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.